7RQ-58430-70702
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 481 / MI
- Registered
- 2021-05-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-08
Registered in v-safe
-
2021-05-08
Dose 1 — Pfizer-BioNTech
- 2021-05-08
-
2021-05-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-10
-
2021-05-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-12
-
2021-05-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-14
- 2021-05-15
-
2021-05-22
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: Fair · Be unable to workFree text: I felt tired most of the time during the week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-29
Dose 2 — Pfizer-BioNTech
- 2021-05-29
-
2021-05-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-31
-
2021-06-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-06-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-06-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-06-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-06-05
- 2021-06-12
- 2021-06-21
-
2021-06-26
Survey response — day 28, dose 2MedDRA: Fatigue, Headache, Impaired work ability — Feeling: Fair · Be unable to work or attend schoolFree text: Ive been experiencing fatigue, sometimes accompanied by headache, on a daily basis that has been affecting my performance at work. It is not very serious, but it has been quite persistent.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-03
- 2021-07-10
-
2021-08-28
Survey response — 3 months, dose 2MedDRA: Disturbance in attention, Dyspnoea, Headache — Feeling: FairFree text: It is hard for me to concentrate on things that require intellectual labor for many hours without experience of headaches or a minor shortness of breath. I can still work but I am not as efficient as before.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-05-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-08 | Pfizer-BioNTech | |
| 2 | 2021-05-29 | Pfizer-BioNTech |
Free text
Release 8 — day 14, dose 1
Symptoms: I felt tired most of the time during the week.
Release 9 — day 28, dose 2
Symptoms: Ive been experiencing fatigue, sometimes accompanied by headache, on a daily basis that has been affecting my performance at work. It is not very serious, but it has been quite persistent.
Release 9 — 3 months, dose 2
Symptoms: It is hard for me to concentrate on things that require intellectual labor for many hours without experience of headaches or a minor shortness of breath. I can still work but I am not as efficient as before.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Disturbance in attention | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Impaired work ability | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release